Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16946001rdf:typepubmed:Citationlld:pubmed
pubmed-article:16946001lifeskim:mentionsumls-concept:C0162371lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C0882849lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C2348480lld:lifeskim
pubmed-article:16946001lifeskim:mentionsumls-concept:C1516240lld:lifeskim
pubmed-article:16946001pubmed:issue9lld:pubmed
pubmed-article:16946001pubmed:dateCreated2006-9-1lld:pubmed
pubmed-article:16946001pubmed:abstractTextWe examined whether ex vivo expansion of umbilical cord blood progenitor cells affected their capacity to generate immune cells such as T lymphocytes (TLs) and dendritic cells (DCs). The capacity to generate TLs from cord blood CD34(+) cells expanded for 14 days (d14) was compared with that of nonexpanded CD34(+) cells (d0) using fetal thymus organ cultures or transfer into nonobese diabetic/severe combined immunodeficient mice. The cell preparations yielded comparable percentages of immature (CD4(+)CD8(-), CD4(+)CD8(+)) TLs and functional mature (CD3(+)CD4(+), CD3(+)CD8(+)) TLs with an analogous TCR (T-cell receptor)-Vbeta repertoire pattern. As regards DCs, d0 and d14 CD34(+) cells also yielded similar percentages of CD1a(+) DCs with the same expression levels of HLA-DR, costimulatory and adhesion molecules, and chemokine receptors. DCs derived from either d14 or d0 CD34(+) stimulated allogeneic TLs to the same extent, and the cytokine pattern production of these allogeneic TLs was similar with no shift toward a predominant Th1 or Th2 response. Even though the intrinsic capacity of d14 CD34(+) cells to generate DCs was 13-fold lower than that of d0 CD34(+) cells, this reduction was offset by the prior amplification of the CD34(+) cells, resulting in the overall production of 15-fold more DCs. These data indicate that ex vivo expansion of CD34(+) cells does not impair T lymphopoiesis nor DC differentiation capacity.lld:pubmed
pubmed-article:16946001pubmed:languageenglld:pubmed
pubmed-article:16946001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16946001pubmed:citationSubsetIMlld:pubmed
pubmed-article:16946001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16946001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16946001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16946001pubmed:statusMEDLINElld:pubmed
pubmed-article:16946001pubmed:monthSeplld:pubmed
pubmed-article:16946001pubmed:issn1066-5099lld:pubmed
pubmed-article:16946001pubmed:authorpubmed-author:RosenzwajgMic...lld:pubmed
pubmed-article:16946001pubmed:authorpubmed-author:KobariLadanLlld:pubmed
pubmed-article:16946001pubmed:authorpubmed-author:DouayLucLlld:pubmed
pubmed-article:16946001pubmed:authorpubmed-author:GiarratanaMar...lld:pubmed
pubmed-article:16946001pubmed:authorpubmed-author:GluckmanJean...lld:pubmed
pubmed-article:16946001pubmed:issnTypePrintlld:pubmed
pubmed-article:16946001pubmed:volume24lld:pubmed
pubmed-article:16946001pubmed:ownerNLMlld:pubmed
pubmed-article:16946001pubmed:authorsCompleteYlld:pubmed
pubmed-article:16946001pubmed:pagination2150-7lld:pubmed
pubmed-article:16946001pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:meshHeadingpubmed-meshheading:16946001...lld:pubmed
pubmed-article:16946001pubmed:year2006lld:pubmed
pubmed-article:16946001pubmed:articleTitleEx vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells.lld:pubmed
pubmed-article:16946001pubmed:affiliationLaboratoire d'Hématologie, Unité de Formation et de Recherche EA1638, Université Pierre et Marie Curie, CHU Saint Antoine, Paris, France.lld:pubmed
pubmed-article:16946001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16946001pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16946001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16946001lld:pubmed